Commentary

Douglas has Parkinson disease and delirium, but neither diagnosis explains every new change. Early in the admission, disrupted delivery of his regular medicines contributes to worse movement and swallowing. Medication reconciliation must therefore establish both the prescription and whether each dose was administered at the intended time. Problems taking oral medication require prompt specialist advice, not unsupervised omission or improvised substitution [G07].

Later, after some improvement, Douglas becomes more drowsy. The team compares this with the previous day's function and repeats clinical assessment. Urinary retention and a new respiratory infection are found. The examination and history determine the next investigations; clinicians should not apply the same tests to every deterioration [G01].

Medication decisions also require attention to Parkinson disease. Antipsychotic harms are particularly relevant, and a general agitation prescription should not be applied automatically. The case uses explanation, assessment of needs and specialist input rather than introducing a drug solely because he is difficult to move.

The endpoint is an incomplete recovery with more help required than before admission. The hospital-complication evidence supports continued attention to swallowing, mobility and devices throughout delirium [P43]. Learners can discuss how to describe a new change precisely: what Douglas could do yesterday, what he is unable to do now, and which signs accompany it. A documented delirium diagnosis should prompt more precise observation without closing the assessment.

An anonymised composite case that does not describe one identifiable person and is not research evidence.